dipyridamole has been researched along with deoxycytidine in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (37.50) | 18.7374 |
1990's | 4 (25.00) | 18.2507 |
2000's | 4 (25.00) | 29.6817 |
2010's | 2 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Daddona, PE; Kelley, WN; Mejias, E; Mitchell, BS | 1 |
Patel, SS; Szebeni, J; Wahl, LM; Weinstein, JN | 1 |
Coons, T; McCartan, K; Rockwell, S; Ullman, B | 1 |
Bover, L; Cabral, S; Leis, S; Mordoh, J; Nembrot, M | 1 |
Ammann, AJ; Cowan, MJ; Martin, DW; Wara, DW | 1 |
Lui, MS; Weber, G; Zhen, YS | 1 |
Jarvis, SM; McBride, D; Young, JD | 1 |
Sasvari-Szekely, M; Solymossy, M; Staub, M; Szikla, K | 1 |
Bamberger, U; Boven, E; Feller, N; Jansen, WJ; Pinedo, HM; van der Wilt, CL | 1 |
Belt, JA; Cass, CE; Crawford, CR; Mackey, JR; Mani, RS; Mowles, D; Selner, M; Young, JD | 1 |
Hirano, H; Ikuma, H; Imai, T; Kadowaki, S; Mitsui, Y; Miyashita, K; Murata, T; Nakamura, T; Nobuoka, Y; Tanigawa, K; Taoka, H; Umino, W; Yamashita, M; Yoshimine, S | 1 |
Ahmad, I; Ahmad, MU; Ali, SM; Chen, P; Chien, PY; Khan, AR; Sheikh, S | 1 |
Curigliano, G; Danesi, R; De Braud, F; De Cobelli, O; Del Tacca, M; Giovannetti, E; Mey, V; Nannizzi, S; Pece, S; Verweij, F | 1 |
Borch, RF; Peters, GJ; Sigmond, J; Wu, W | 1 |
Adema, AD; Honeywell, RJ; Losekoot, N; Myhren, F; Peters, GJ; Sandvold, ML; Smid, K; Verheul, HM | 1 |
Baker, SD; Blum, W; Drenberg, CD; Du, G; Gibson, AA; Gruber, TA; Hu, S; Li, L; Nies, AT; Pabla, N; Pounds, SB; Rhinehart, DP; Schwab, M; Shi, L; Sparreboom, A | 1 |
1 trial(s) available for dipyridamole and deoxycytidine
Article | Year |
---|---|
In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients.
Topics: Administration, Intravesical; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Deoxycytidine Kinase; Dipyridamole; Dose-Response Relationship, Drug; Drug Synergism; Equilibrative Nucleoside Transporter 1; Excitatory Amino Acid Antagonists; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Glutamates; Guanine; Humans; Male; Middle Aged; Neoplasm Staging; Pemetrexed; Phosphoribosylglycinamide Formyltransferase; Phosphorylation; Proto-Oncogene Proteins c-akt; S Phase; Thioinosine; Thymidylate Synthase; Treatment Outcome; Urinary Bladder Neoplasms | 2006 |
15 other study(ies) available for dipyridamole and deoxycytidine
Article | Year |
---|---|
Purinogenic immunodeficiency diseases: selective toxicity of deoxyribonucleosides for T cells.
Topics: B-Lymphocytes; Cell Line; Deoxyadenine Nucleotides; Deoxyadenosines; Deoxycytidine; Deoxyguanine Nucleotides; Deoxyguanosine; Deoxyribonucleosides; Dipyridamole; Immunologic Deficiency Syndromes; T-Lymphocytes | 1978 |
Differential inhibition of 2'-deoxycytidine salvage as a possible mechanism for potentiation of the anti-human immunodeficiency virus activity of 2',3'-dideoxycytidine by dipyridamole.
Topics: Antiviral Agents; Chromatography, High Pressure Liquid; Deoxycytidine; Dipyridamole; Drug Synergism; HIV-1; Humans; Monocytes; Phosphorylation; Zalcitabine | 1991 |
Genetic analysis of 2',3'-dideoxycytidine incorporation into cultured human T lymphoblasts.
Topics: Acquired Immunodeficiency Syndrome; Biological Transport; Cell Division; Cell Survival; Deoxycytidine; Deoxycytidine Kinase; Dipyridamole; Humans; Kinetics; Leukemia, Lymphoid; Mutation; Nucleosides; Phosphorylation; Phosphotransferases; T-Lymphocytes; Thioinosine; Tumor Cells, Cultured; Zalcitabine | 1988 |
Dipyridamole inhibits reversion by thymidine of methotrexate effect and increases drug uptake in Sarcoma 180 cells.
Topics: Animals; Biological Transport; Deoxycytidine; Deoxyuridine; Dipyridamole; DNA Replication; Drug Antagonism; Kinetics; Methotrexate; Mice; Sarcoma 180; Thymidine; Thymine Nucleotides | 1984 |
Dipyridamole and intravenous deoxycytidine therapy in a patient with adenosine deaminase deficiency.
Topics: Adenosine Deaminase; Administration, Oral; Child; Cytidine Deaminase; Deoxycytidine; Dipyridamole; Drug Evaluation; Female; Humans; Immunologic Deficiency Syndromes; Infusions, Parenteral; Nucleoside Deaminases; Time Factors | 1983 |
Effects of acivicin and dipyridamole on hepatoma 3924A cells.
Topics: Animals; Antimetabolites, Antineoplastic; Biological Transport; Deoxycytidine; Dipyridamole; Isoxazoles; Kinetics; Liver Neoplasms, Experimental; Oxazoles; Rats; Ribonucleosides | 1983 |
Erythrocyte nucleoside transport: asymmetrical binding of nitrobenzylthioinosine to nucleoside permeation sites.
Topics: Animals; Binding Sites; Binding, Competitive; Biological Transport; Cell Membrane Permeability; Deoxycytidine; Dipyridamole; Erythrocytes; Humans; Inosine; Kinetics; Nucleosides; Sheep; Thioinosine; Uridine | 1982 |
Nucleoside transport and metabolism in lymphocytes, polymorphonuclear cells and cerebral synaptosomes.
Topics: Adenosine; Animals; Biological Transport; Cerebral Cortex; Child; Deoxycytidine; Dilazep; Dipyridamole; DNA; Humans; Kinetics; Lymphocytes; Neutrophils; Nucleosides; Palatine Tonsil; Papaverine; Rats; Synaptosomes; Thioinosine; Thymidine; Uridine | 1994 |
The influence of BIBW22BS, a dipyridamole derivative, on the antiproliferative effects of 5-fluorouracil, methotrexate and gemcitabine in vitro and in human tumour xenografts.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Deoxycytidine; Dipyridamole; Doxorubicin; Drug Resistance; Female; Floxuridine; Fluorouracil; Gemcitabine; Humans; Methotrexate; Mice; Mice, Nude; Morpholines; Neoplasms; Neoplasms, Experimental; Protein Binding; Transplantation, Heterologous; Triamterene; Tumor Cells, Cultured; Vincristine | 1995 |
Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines.
Topics: Animals; Antimetabolites, Antineoplastic; Biological Transport; Carrier Proteins; Cell Division; Cell Survival; Deoxycytidine; Dipyridamole; DNA, Complementary; Gemcitabine; HeLa Cells; Humans; K562 Cells; Kinetics; Membrane Proteins; Membrane Transport Proteins; Nucleoside Transport Proteins; Recombinant Proteins; Thioinosine; Transfection; Tumor Cells, Cultured | 1998 |
[Adjuvant chemotherapy for unresectable locally advanced pancreatic cancer in light of its characteristics].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Deoxycytidine; Dipyridamole; Drug Administration Schedule; Female; Fluorouracil; Gemcitabine; Humans; Leucovorin; Male; Middle Aged; Mitomycin; Neoplasm Staging; Pancreatic Neoplasms | 2004 |
In-vitro and in-vivo anti-cancer activity of a novel gemcitabine-cardiolipin conjugate.
Topics: Animals; Antineoplastic Agents; Body Weight; Cardiolipins; Cell Proliferation; Deoxycytidine; Dipyridamole; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Gemcitabine; HT29 Cells; Humans; Leukemia P388; Leukocyte Count; Mice; Mice, SCID; Neutropenia; Nucleoside Transport Proteins; Pancreatic Neoplasms; Thioinosine; Xenograft Model Antitumor Assays | 2006 |
Synthesis and biological activity of a gemcitabine phosphoramidate prodrug.
Topics: Antimetabolites, Antineoplastic; Cell Line, Tumor; Cytidine Monophosphate; Deoxycytidine; Deoxycytidine Kinase; Dipyridamole; Drug Screening Assays, Antitumor; Gemcitabine; Humans; Nucleoside Transport Proteins; Prodrugs; Structure-Activity Relationship | 2007 |
Metabolism and accumulation of the lipophilic deoxynucleoside analogs elacytarabine and CP-4126.
Topics: Antineoplastic Agents; Cell Line; Cytarabine; Deoxycytidine; Deoxycytidine Kinase; Dipyridamole; Drug Resistance, Neoplasm; Gemcitabine; Humans; Leukemia; Nucleoside Transport Proteins; Nucleotidases | 2012 |
OCTN1 Is a High-Affinity Carrier of Nucleoside Analogues.
Topics: Animals; Antimetabolites, Antineoplastic; Child; CHO Cells; Cohort Studies; Cricetulus; Cytarabine; Deoxycytidine; Dipyridamole; Drug Resistance, Neoplasm; Gemcitabine; Gene Expression Profiling; HEK293 Cells; HeLa Cells; Humans; Leukemia, Myeloid, Acute; Organic Cation Transport Proteins; Symporters | 2017 |